Amylyx Pharmaceuticals, Inc. (AMLX)
32.63
-0.52
(-1.57%)
USD |
NASDAQ |
Sep 16, 16:00
33.00
+0.37
(+1.13%)
After-Hours: 05:04
Amylyx Pharmaceuticals Total Return Level : 32.63 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 32.63 |
| September 15, 2026 | 33.15 |
| September 14, 2026 | 33.64 |
| September 11, 2026 | 31.62 |
| September 10, 2026 | 32.09 |
| September 09, 2026 | 32.40 |
| September 08, 2026 | 33.88 |
| September 04, 2026 | 34.10 |
| September 03, 2026 | 33.96 |
| September 02, 2026 | 34.49 |
| September 01, 2026 | 33.81 |
| August 31, 2026 | 33.75 |
| August 28, 2026 | 34.74 |
| August 27, 2026 | 37.18 |
| August 26, 2026 | 37.08 |
| August 25, 2026 | 37.46 |
| August 24, 2026 | 38.15 |
| August 21, 2026 | 38.66 |
| August 20, 2026 | 39.66 |
| August 19, 2026 | 38.60 |
| August 18, 2026 | 35.11 |
| August 17, 2026 | 21.43 |
| August 14, 2026 | 21.63 |
| August 13, 2026 | 22.48 |
| August 12, 2026 | 23.35 |
| Date | Value |
|---|---|
| August 11, 2026 | 23.63 |
| August 10, 2026 | 22.67 |
| August 07, 2026 | 22.82 |
| August 06, 2026 | 24.19 |
| August 05, 2026 | 21.85 |
| August 04, 2026 | 21.87 |
| August 03, 2026 | 20.17 |
| July 31, 2026 | 20.31 |
| July 30, 2026 | 20.75 |
| July 29, 2026 | 19.73 |
| July 28, 2026 | 19.55 |
| July 27, 2026 | 19.49 |
| July 24, 2026 | 18.41 |
| July 23, 2026 | 17.59 |
| July 22, 2026 | 17.70 |
| July 21, 2026 | 18.50 |
| July 20, 2026 | 17.45 |
| July 17, 2026 | 17.75 |
| July 16, 2026 | 17.02 |
| July 15, 2026 | 17.78 |
| July 14, 2026 | 18.20 |
| July 13, 2026 | 17.41 |
| July 10, 2026 | 17.77 |
| July 09, 2026 | 18.38 |
| July 08, 2026 | 17.88 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Pfizer Inc. | 91.85 |
| Eli Lilly & Co. | 3006.36 |
| Merck & Co., Inc. | 448.12 |
| EyePoint, Inc. | 3.45 |
| Bristol Myers Squibb Co. | 240.63 |